Immunoglobulin Infusion as Therapy Against Influenza?

Tekijä Huckriede, Anke
Julkaisussa EBioMedicine (2017)

Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review

Tekijä van Doorn, Eva, Liu, Heng, Huckriede, Anke, Hak, Eelko
Julkaisussa Hum Vaccin Immunother (2015)

Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations

Tekijä Tapia-Calle, Gabriela, Stoel, Maaike, de Vries-Idema, Jacqueline, Huckriede, Anke
Julkaisussa Vaccines (Basel) (2017)

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100

Tekijä Liu, Heng, Patil, Harshad P., de Vries-Idema, Jacqueline, Wilschut, Jan, Huckriede, Anke
Julkaistu 2012

Evaluation of Mucosal and Systemic Immune Responses Elicited by GPI-0100- Adjuvanted Influenza Vaccine Delivered by Different Immunization Strategies

Tekijä Liu, Heng, Patil, Harshad P., de Vries-Idema, Jacqueline, Wilschut, Jan, Huckriede, Anke
Julkaistu 2013

Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs

Tekijä Geeraedts, Felix, Bungener, Laura, Pool, Judith, Ter Veer, Wouter, Wilschut, Jan, Huckriede, Anke
Julkaisussa Influenza Other Respir Viruses (2008)

Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production

Tekijä Herrera-Rodriguez, José, Signorazzi, Aurora, Holtrop, Marijke, de Vries-Idema, Jacqueline, Huckriede, Anke
Julkaisussa Vaccine (2019)

Simplifying Influenza Vaccination During Pandemics: Sublingual Priming and Intramuscular Boosting of Immune Responses with Heterologous Whole Inactivated Influenza Vaccine

Tekijä Murugappan, Senthil, Patil, Harshad P., Frijlink, Henderik W., Huckriede, Anke, Hinrichs, Wouter L. J.
Julkaistu 2014

Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination

Tekijä Bhide, Yoshita, Dong, Wei, Meijerhof, Tjarko, de Vries‐Idema, Jacqueline, Niesters, Hubert G., Huckriede, Anke
Julkaisussa Immun Inflamm Dis (2020)

Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration

Tekijä Budimir, Natalija, de Haan, Aalzen, Meijerhof, Tjarko, Gostick, Emma, Price, David A., Huckriede, Anke, Wilschut, Jan
Julkaistu 2013

In Vitro Characterization of the Innate Immune Pathways Engaged by Live and Inactivated Tick-Borne Encephalitis Virus

Tekijä Signorazzi, Aurora, Pennings, Jeroen L. A., Etna, Marilena P., Noya, Malou, Coccia, Eliana M., Huckriede, Anke
Julkaisussa Vaccines (Basel) (2021)

Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity

Tekijä Budimir, Natalija, Huckriede, Anke, Meijerhof, Tjarko, Boon, Louis, Gostick, Emma, Price, David A., Wilschut, Jan, de Haan, Aalzen
Julkaistu 2012

Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA

Tekijä de Jonge, Jørgen, Leenhouts, Johanna M., Holtrop, Marijke, Schoen, Pieter, Scherrer, Peter, Cullis, Pieter R., Wilschut, Jan, Huckriede, Anke
Julkaistu 2007

Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus

Tekijä Bhide, Yoshita, Tomar, Jasmine, Dong, Wei, de Vries-Idema, Jacqueline, Frijlink, Henderik W., Huckriede, Anke, Hinrichs, Wouter L. J.
Julkaisussa Drug Deliv (2018)

Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling

Tekijä Geeraedts, Felix, Goutagny, Nadege, Hornung, Veit, Severa, Martina, de Haan, Aalzen, Pool, Judith, Wilschut, Jan, Fitzgerald, Katherine A., Huckriede, Anke
Julkaistu 2008

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant

Tekijä Saluja, Vinay, Amorij, Jean P., van Roosmalen, Maarten L., Leenhouts, Kees, Huckriede, Anke, Hinrichs, Wouter L. J., Frijlink, Henderik W.
Julkaistu 2010

Critical Role of TLR7 Signaling in the Priming of Cross-Protective Cytotoxic T Lymphocyte Responses by a Whole Inactivated Influenza Virus Vaccine

Tekijä Budimir, Natalija, de Haan, Aalzen, Meijerhof, Tjarko, Waijer, Simke, Boon, Louis, Gostick, Emma, Price, David A., Wilschut, Jan, Huckriede, Anke
Julkaistu 2013

Innate Responses Induced by Whole Inactivated Virus or Subunit Influenza Vaccines in Cultured Dendritic Cells Correlate with Immune Responses In Vivo

Tekijä Stoel, Maaike, Pool, Judith, de Vries-Idema, Jacqueline, Zaaraoui-Boutahar, Fatiha, Bijl, Maarten, Andeweg, Arno C., Wilschut, Jan, Huckriede, Anke
Julkaisussa PLoS One (2015)

A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro

Tekijä Tapia-Calle, Gabriela, Born, Philip A., Koutsoumpli, Georgia, Gonzalez-Rodriguez, Martin Ignacio, Hinrichs, Wouter L. J., Huckriede, Anke L. W.
Julkaisussa Vaccines (Basel) (2019)

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures

Tekijä Geeraedts, Felix, Saluja, Vinay, ter Veer, Wouter, Amorij, Jean-Pierre, Frijlink, Henderik W., Wilschut, Jan, Hinrichs, Wouter L. J., Huckriede, Anke
Julkaistu 2010